Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
What Advanced files
- Others52
- Investor Meet40
- Updates19
- Board Meeting11
- Dividend/Bonus9
- PPTs9
Advanced Enzyme Technologies Limited has extinguished 8,25,028 fully paid-up equity shares bought back through the open market route. This capital reduction lowers the total outstanding equity base, potentially enhancing shareholder value.
Advanced Enzyme Technologies' Board approved a buyback up to ₹ 69.7 Cr via the open market. The maximum price for the buyback is ₹ 500 per share, aiming to repurchase up to 13.94 lakh shares, representing about 1.24% of current paid-up equity. The offer is expected to open within 4...
ADVENZYMES' Board approved a share buyback of up to ₹69.70 Cr. The company will repurchase shares from the open market at a maximum price of ₹500 per share. The buyback offer opens on or before August 14, 2026, and is set to close by November 20, 2026, or earlier if...
Advanced Enzyme Technologies has set July 24, 2026, as the Record Date for its proposed final dividend of ₹1.35 per equity share for FY26. Shareholders holding shares on this date will be eligible for the dividend, subject to approval at the 37th AGM on July 31, 2026. If approved, the...
Advanced Enzyme Technologies' board recently met and made key decisions for shareholders. A final dividend of ₹1.35 per equity share (67.5%) for FY25-26 was proposed, pending approval at the upcoming AGM. Payment, if approved, will commence two days post-AGM. The Board also decided to defer an interim dividend, aiming to...